课题基金 / 基金详情

Injectable bioactive hydrogel for the regeneration of intervertebral disc

Injectable bioactive hydrogel for the regeneration of intervertebral disc
用于椎间盘再生的可注射生物活性水凝胶
批准号:
508365-2017
负责人:
Lerouge, Sophie
金额:
$15.13万
依托单位国家:
加拿大
项目类别:
Collaborative Health Research Projects
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Lerouge, Sophie的其他基金

相似基金

相关文献

中文摘要
翻译
椎间盘允许椎骨轻微运动,在脊柱减震中发挥重要作用,但随着时间的推移会受损。椎间盘退变是导致下腰痛的主要原因之一,它影响了全球大部分人口,造成了巨大的社会经济负担。这是如此普遍,大约有1在50加拿大人成为 ** 残疾的背部疼痛。当药物或物理治疗不充分时,手术是唯一的选择,其中 ** 包括椎间盘切除和/或植入物置换。明确需要 ** 椎间盘的微创修复,以避免手术治疗和简单取出椎间盘后影响患者的长期并发症。该项目旨在为受损的椎间盘 ** 提供一种微创治疗,其基础是使用一种材料,这种材料可以通过针头注入椎间盘并 ** 迅速固化。这种材料与细胞和生物活性产品相结合,可以积极 ** 促进组织的修复,以更好地恢复其机械性能和 ** 其正常组成。这种注射产品也应该有修复 ** 软骨的潜力,这会影响更多的患者。两家加拿大公司对这种产品很感兴趣。因此,除了改善加拿大人的健康外,该项目还将有助于加强加拿大在这一战略领域最近的工业。
英文摘要
Intervertebral discs allow slight movement of the vertebrae and play an important role in**shock absorption in the spine but can be damaged with time. Disc degeneration is one of the**leading causes of low back pain, which affects a large proportion of the global population at a**huge socioeconomic burden. It is so common that approximately 1 in 50 Canadians become**disabled by back pain.**When drugs or physical therapy are not sufficient, surgery is the only offered option which**consists in the removal of the disc and/or its replacement by an implant. There is a clear need**for minimally invasive repair of the intervertebral disc to avoid surgical treatment and long**term complications which affect patients after simple removal of the disc.**The project aims to provide a minimally invasive treatment for damaged intervertebral discs**based on the use of a material which can be injected into the disk through a needle and**rapidly solidify. This material is combined with cells and bioactive products that can actively**promote the reparation of the tissue, in order to better restore its mechanical properties and**its normal composition. This injectable product should also have potential for the repair of**cartilage, which affects an even higher number of patients.**Two Canadians companies are strongly interested in this product. Therefore, in addition to the**improvement of the health of Canadians, this project will help reinforce the quite recent**Canadian industry in this strategic field
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modular injectable scaffolds for cell therapy and 3D bioprinting
  • 批准号:
    RGPIN-2020-06684
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.01万
  • 财政年份:
    2022
  • 负责人:
    Lerouge, Sophie
  • 依托单位:
Modular injectable scaffolds for cell therapy and 3D bioprinting
  • 批准号:
    RGPIN-2020-06684
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.01万
  • 财政年份:
    2021
  • 负责人:
    Lerouge, Sophie
  • 依托单位:
Modular injectable scaffolds for cell therapy and 3D bioprinting
  • 批准号:
    RGPIN-2020-06684
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.01万
  • 财政年份:
    2020
  • 负责人:
    Lerouge, Sophie
  • 依托单位:
Injectable thermosensitive hydrogels with enhanced mechanical properties for cell therapy
  • 批准号:
    RGPIN-2015-05169
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.55万
  • 财政年份:
    2019
  • 负责人:
    Lerouge, Sophie
  • 依托单位:
国内基金
海外基金
中药复方“芍药甘草汤”活性成分的单克隆抗体制备及剔除分析法的建立
  • 批准号:
    30572316
  • 项目类别:
    面上项目
  • 资助金额:
    28.0万元
  • 批准年份:
    2005
  • 负责人:
    徐金森
  • 依托单位:
新功能肽Aglycin降低高血糖的机理和药理研究
  • 批准号:
    30470823
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2004
  • 负责人:
    陈正望
  • 依托单位: